XCUR earnings date and last-quarter result: last quarter beat, P/E -1.14. Updated 2026-07-23.
Exicure (XCUR) Research Hub
Exicure (XCUR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 1.09 USD (+3.81%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.14, market cap 0.01B. This hub links to the full technical, earnings and options research available for XCUR.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.09 USD (+3.81%) |
| 52-week range | 0.936 USD – 3.2 USD |
| Trend regime | Range |
| 14-day RSI | 50.7 (Neutral) |
| Trailing P/E | -1.14 |
| Market cap | 0.01B |
| Dividend yield | 0.00% |
Available research for XCUR
Covered Call on XCUR: how it works, illustrative setup around the real 1.09 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on XCUR: how it works, illustrative setup around the real 1.09 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on XCUR: how it works, illustrative setup around the real 1.09 USD price, max profit/loss, breakeven and when to use it. Educational.
XCUR technical analysis: range, last 1.09 USD, RSI 50.7, 52w range 0.936 USD–3.2 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is XCUR in?
Exicure (XCUR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is XCUR in an uptrend or downtrend?
As of 2026-10-26, XCUR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is XCUR's trailing P/E ratio?
XCUR's trailing P/E is -1.14, with a market cap of 0.01B. See the earnings research page for full valuation detail.